The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
* This Week in the Journal
 August 28, 2008
 Audio Icon Audio Summary
*
Correspondence
* Initial Treatment of HIV-1 Infection
* Treatment of Hypertension in the Elderly
* Keratoderma Blennorrhagicum–like Rash
* Scrotal Cutaneous Side Effects of Sunitinib
* Widespread Amyloid Deposition in Transplanted Human Pancreatic Islets
*
Book Reviews
* Jacob's Legacy: A Genetic View of Jewish History
* Scientific Errors and Controversies in the U.S. HIV/AIDS Epidemic: How They Slowed Advances and Were Resolved
* The Oxford Textbook of Clinical Research Ethics
*
Continuing Medical Examination
* Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
* Management of Acute Bleeding from a Peptic Ulcer
* Case 27-2008: A 64-Year-Old Man with Abdominal Pain, Nausea, and an Elevated Level of Serum Creatinine
Original Articles
Magnesium Sulfate for the Prevention of Cerebral Palsy

In this multicenter, placebo-controlled, randomized trial of intravenous magnesium sulfate in women at imminent risk for delivery between 24 and 31 weeks of gestation, magnesium sulfate did not significantly reduce the primary composite outcome of moderate or severe cerebral palsy or death. However, it did result in a reduced rate of cerebral palsy among survivors (a prespecified secondary outcome), which may suggest the possibility of benefit.

Related Editorial


Original Articles
Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

Patients with newly diagnosed multiple myeloma who were ineligible for treatment with high-dose chemotherapy plus hematopoietic stem-cell transplantation were randomly assigned to receive either melphalan and prednisone alone or melphalan and prednisone plus bortezomib. The time to disease progression (the primary outcome) was longer in the bortezomib group. The combination of bortezomib, melphalan, and prednisone appears to be effective as initial treatment in patients with multiple myeloma who cannot withstand high-dose therapy.

Related Editorial


Original Articles
Brain-Derived Neurotrophic Factor and Obesity in WAGR Syndrome

This study examined genotype and body-mass index in patients with the Wilms' tumor, aniridia, genitourinary anomalies, and mental retardation (WAGR) syndrome. The related genes WT1 and PAX6 are on chromosome 11p13, centromeric to brain-derived neurotrophic factor (BDNF), an important gene in energy homeostasis. BDNF haploinsufficiency was linked to childhood-onset obesity and reduced levels of serum BDNF, suggesting a role of BDNF in energy homeostasis.

Related Perspective


Review Article
Current Concepts: Acute Bleeding from a Peptic Ulcer

The mortality associated with acute bleeding from a peptic ulcer remains high (5 to 10%), and the condition accounts for more than 400,000 hospital admissions per year in the United States. This review summarizes the approach to patient triage and risk stratification, the goals of early endoscopy, the options for medical therapy, and the role of surgery and interventional radiology.


Review Article
Mechanisms of Disease: Mechanisms of Thrombus Formation

This review is an account of recent advances in our understanding of the mechanisms of thrombus formation, with emphasis on two independent pathways: one involving primarily platelets, and the other initiated by tissue factor. The review includes information from new studies of microparticles in the circulation that display tissue derived from injured cells, cancer cells, and inflammatory cells. It ends with a discussion of the clinical implications for prevention and management of thrombosis. A video showing thrombus formation in vivo is available at www.nejm.org.


Case Records of the Massachusetts General Hospital
A Man with Abdominal Pain, Nausea, and an Elevated Level of Serum Creatinine

A 64-year-old man was admitted to the hospital because of abdominal pain, nausea, and an elevated serum creatinine level. He had a history of recurrent epigastric pain, which had been attributed to pancreatitis and gastroesophageal reflux disease. One week before admission, epigastric pain recurred, with nausea and vomiting; 3 days before admission, he stopped all oral intake, but symptoms worsened. On admission, the serum creatinine level was 3.5 mg per deciliter, and the urea nitrogen level was 28 mg per deciliter. Intravenous fluids were administered, without improvement. A diagnostic procedure was performed.


Clinical Implications of Basic Research
Intraocular Neovascularization and Edema

Topical application of inhibitors of growth factor receptors or their signaling pathways protects against choroidal neovascularization, vascular leakage, and retinal edema in mice.


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.